Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000481158 | SCV000567225 | uncertain significance | not provided | 2016-09-22 | criteria provided, single submitter | clinical testing | This variant is denoted MLH1 c.-37A>G, and describes a nucleotide substitution 37 base pairs upstream of the MLH1 ATG translational start site in the 5' untranslated region (UTR). The surrounding sequence, with the base that is substituted in braces, is GTTG[A/G]GCAT. This variant has not, to our knowledge, been reported in the literature as pathogenic or benign. MLH1 c.-37A>G does not appear to affect the start codon or the Kozak translational consensus sequence. Of note, constitutional epigenetic silencing of MLH1 has been suggested as an alternate mechanism responsible for Lynch syndrome, and other variants located within the 5' UTR have been shown to result in allele-specific promoter methylation and subsequent transcriptional silencing (Hitchins 2011, Ward 2013). This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The nucleotide which is altered, an adenine (A), is conserved among mammals. Based on currently available information, it is unclear whether MLH1 c.-37A>G is pathogenic or benign. We consider it to be a variant of uncertain significance. |